T0	Outcomes 76 134	pharmacokinetics and pharmacodynamics of racemic warfarin.
T1	Outcomes 334 398	no major change in the pharmacokinetics of (R)- or (S)-warfarin.
T2	Outcomes 412 474	did not alter the pharmacodynamic profile of racemic warfarin.
T3	Outcomes 488 520	increased template bleeding time